Cilastatin Sodium; Imipenem; Relebactam Patent Expiration

Cilastatin Sodium; Imipenem; Relebactam is Used for treating complicated urinary tract infections. It was first introduced by Merck Sharp And Dohme Corp A Sub Of Merck And Co Inc in its drug Recarbrio on Jul 16, 2019.


Cilastatin Sodium; Imipenem; Relebactam Patents

Given below is the list of patents protecting Cilastatin Sodium; Imipenem; Relebactam, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Recarbrio US8487093 β-lactamase inhibitors Nov 19, 2029 Msd Merck Co


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳